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Abstract Deoxyribonuclease I (DNase I) was confirmed to be
expressed in the human pituitary gland, particularly the anterior
lobe, at levels comparable to those in the pancreas. The DNase I
activity and the amount of gene transcript present in the pituitary
glands of individuals aged from 1 month to 89 years was
significantly age-dependent, with an abrupt elevation after the
neonatal and prepubertal periods irrespective of gender, followed
by a gradual age-dependent decline in males and a marked
reduction in females in their postreproductive period. This DNase
I age dependence in the pituitary gland was not present in the
pancreas and serum. These observations suggest that tissue-
specific up-regulation of DNase I gene expression in the pituitary
gland occur, possibly at the onset of puberty. ß 2002 Federa-
tion of European Biochemical Societies. Published by Elsevier
Science B.V. All rights reserved.
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1. Introduction
The primary role of deoxyribonuclease I (DNase I, EC
3.1.21.1) has been considered to be the digestion of DNA
for nutritional purposes. However, a recent report [1] which
showed that the absence of DNase I activity may be a critical
factor in the initiation of systemic lupus erythematosus sug-
gested that the enzyme has some other physiological func-
tion(s) in vivo. One of its proposed roles is DNA breakdown
during apoptosis, leading to cell death in a gene-controlled
manner [2,3]. Our comparative studies of lower to higher ver-
tebrates with regard to tissue distribution of DNase I demon-
strated that the enzyme also exists outside exocrine glands of
the alimentary tract, such as in the pancreas and/or parotid
gland [4^6]. Recently, we have found that somatostatin in-
duces a transient down-regulation of DNase I in rat lower
gut and serum through e¡ects on its gene expression, but
not in the parotid gland which exhibits the highest activity
among rat tissues [7]. Somatostatin is known to inhibit endo-
crine secretion by the pituitary gland [8], reducing levels of
DNase I activity by 50%. Also, up-regulation of DNase I
activity in rat prostate has been observed following androgen
withdrawal by castration [9]. From these ¢ndings we postulate
that DNase I activity coupled to endocrine secretion could be
controlled in a hormone-dependent manner. In this context,
information on physiological changes in DNase I activity in
the endocrine glands, such as the pancreas and the pituitary
gland, in which a substantial DNase I activity could be ob-
served in our preliminary survey [4^6], may be required for
elucidation of potential hormonal regulation of the enzyme.
In this study, we con¢rmed the presence of DNase I in
human pituitary gland and examined the age-related distribu-
tion of DNase I activity and the gene transcript present in
paired samples of human pituitary gland and pancreas. The
results lead us to conclude that the pituitary DNase I is regu-
lated in an age-dependent manner, possibly through its gene
expression.
2. Materials and methods
2.1. Biological samples and materials
Paired samples of human tissues including pituitary gland and pan-
creas were obtained at autopsy from individuals (aged from 1 month
to 89 years) within 15 h after death and stored at 380‡C until use. All
the samples showed no pathological changes. A few samples of the
pituitary gland were divided into two portions: from the anterior and
posterior lobes. Also, serum samples were collected from healthy Jap-
anese individuals. Speci¢c antibodies against human DNase I were
prepared according to the method described previously [10,11]. All
the human samples were acquired and used in accordance with the
guidelines for the scienti¢c use of human materials by the Japanese
Society of Legal Medicine.
2.2. Assay of DNase I and II activities and analytical methods
Enzyme activities of DNases I and II were determined by the single
radial enzyme di¡usion (SRED) method, and quanti¢ed as described
elsewhere [4,10,12]. Brie£y, the human tissues (about 25 mg) were
homogenized in 2 ml Tris^HCl bu¡er (pH 7.5) containing 2 mM
phenylmethylsulfonyl £uoride, and the supernatants obtained by cen-
trifugation at 20 000Ug were used in the subsequent analysis. Immu-
nological and enzymological properties of the enzymes present in each
tissue sample were examined as described previously [6,10]. Isoelectric
focusing in a thin layer of polyacrylamide gel (IEF^PAGE) was per-
formed using Ampholine 3.5^5 (Amersham Pharmacia Biotech, Upp-
sala, Sweden) as a carrier ampholyte. The supernatants from the pi-
tuitary gland and pancreas, and serum that was simultaneously
collected from the same individuals, were subjected to IEF^PAGE
analysis following treatment with sialidase, after which the focused
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DNase I was visualized by activity staining using a dried agarose ¢lm
overlay (DAFO) method, as described previously [13].
2.3. Detection and sequencing of DNase I gene transcripts in human
tissues
RNA was extracted from human pituitary gland and pancreas sam-
ples by the acid guanidinium thiocyanate^phenol^chloroform method
[14]. The DNase I gene transcript was ampli¢ed by reverse transcrip-
tase-PCR and analyzed as described previously [6]. Ampli¢cation of
portions of the total RNA derived from the pituitary gland and pan-
creas collected from a 21-year-old male (obtained at autopsy 12 h
after death caused by loss of blood) using sets of the primers
5P-CTCTGAGGACATCACCATCA-3P and 5P-AGTTCAACTGGT-
GTGGGGAG-3P, corresponding to the 5P-upstream and 3P-down-
stream untranslated regions of the human DNase I cDNA [15], re-
spectively, was performed by reverse transcriptase-PCR. The
ampli¢ed products were subcloned into the pCR II vector (Invitrogen,
San Diego, CA, USA), and sequenced using a Dye Terminator Cycle
Sequencing kit (FS; Applied Biosystems, Urayasu, Japan). The se-
quencing run was carried out on an Applied Biosystems Genetic An-
alyzer (model 310), and all DNA sequences were con¢rmed by reading
both DNA strands.
2.4. Semi-quanti¢cation of DNase I gene transcript levels expressed in
human tissue samples
In order to semi-quantify levels of DNase I gene transcript in the
pituitary gland and pancreas, a competitive PCR method based on a
non-homologous internal standard approach [16] was employed. A
non-homologous DNA fragment with a primer template correspond-
ing to sets of primers 5P-CTGAAGATCGCAGCCTTCAAC-3P
(primer 1) and 5P-CTTCAGCATCACCTCCACTGG-3P (primer 2),
corresponding to the N- and C-terminal portions of the mature hu-
man DNase I [15], tentatively named PCR-MIMIC, was used as a
competitive internal standard during PCR ampli¢cation, and was pre-
pared using a PCR-MIMIC construction kit (Clontech, Palo Alto,
CA, USA) according to the manufacturer’s instructions. A 5^10-
fold dilution series (from 100 to 1035 amol/Wl) of the PCR-MIMIC
was prepared for use in a competitive PCR. A constant amount of the
¢rst-strand cDNA derived from the total RNA of each human pitui-
tary gland and pancreas was subjected to PCR ampli¢cation along
with each of the PCR-MIMIC dilutions. Series of competitive PCRs
using the primer 1/primer 2 set in the copresence of PCR-MIMIC at
di¡erent concentrations were performed separately, and analyzed as
described previously [5,17].
3. Results
3.1. Highest DNase I activity present in human pituitary gland
and pancreas
Similar high levels of DNase I activity were detected in the
human pituitary gland and pancreas derived from the same
individuals (mean þ S.D.: 0.92 þ 1.3 and 1.0 þ 0.73 U/g wet
weight, respectively; n = 80). The human pituitary gland is
composed of two main lobes (anterior and posterior), and
the DNase I activity was only detected in the anterior lobe
in both sexes (n = 4; anterior lobe: 0.48^0.55 U/g wet weight;
posterior lobe: not detected). All the enzyme activity detect-
able in each pituitary extract was completely inhibited by
1 mM EGTA, 1 mM EDTA, or 0.1 nM G-actin which is
known to be a potent inhibitor of human DNase I [10]. Nota-
bly, the activity was completely abolished by anti-human
DNase I antibody. These ¢ndings indicate that the activity
detected in the human pituitary gland was indeed derived
from authentic DNase I. Mammalian DNase I is classi¢ed
into three types: pancreatic, parotid, and pancreatic^parotid
(mixed) [6]. Human DNase I is of the pancreatic type, being
more sensitive to acidic conditions than the other types; the
DNase I activity present in the pituitary extracts was labile
under acidic conditions in the same manner as urinary puri¢ed
DNase I. On the other hand, in rat the DNase I (parotid type)
activity present in the pituitary glands (3.5 þ 0.58U1032 U/g
wet weight; n = 10) was extremely low compared to that in the
parotid (84 þ 22U103 U/g); similar results were seen in mouse
(parotid type). Furthermore, the DNase I (mixed type) activ-
ity in the rabbit pituitary gland was below the detection limit
of our assay (about 0.01 U/g). Therefore, the high levels of
DNase I activity observed in the pituitary gland allowed the
human type to be distinguished from the others.
Genetic polymorphism of human DNase I in body £uids
and the pancreas has been demonstrated by di¡erences in
pI values of phenotype-speci¢c enzymes [18,19]. The IEF^
PAGE patterns of DNase I in the pituitary samples closely
resembled those of the paired samples of pancreas and serum
from the same individuals in each phenotype (Fig. 1). The
phenotypes determined from the pituitary samples were com-
pletely consistent with those from the pancreas or serum
samples of the corresponding individuals. Since DNase I
present in the pituitary gland exhibited the same genetic
polymorphism as that in the pancreas, the enzyme in the
former was obviously derived from the same DNase I gene
expressed in the latter.
3.2. DNase I-speci¢c gene transcript present in the
pituitary gland
A unique fragment corresponding to DNase I-speci¢c
mRNA could be ampli¢ed by reverse transcriptase-PCR
from the total RNA in all the pituitary gland samples with
a detectable DNase I activity, whereas the cerebrum, in which
DNase I activity could not be detected, gave no ampli¢ed
product. Furthermore, the fragment covering the entire region
of the open reading frame in its cDNA, which was ampli¢ed
from each of the pituitary gland and pancreas samples from
the same individual, was subcloned and sequenced. The se-
quence of the pituitary gland-derived clone (DDBJ/EMBL/
GenBank accession number AB004858) was identical to that
from the corresponding pancreas. We could therefore rule out
the possibility that the DNase I activity observed in the pitui-
tary gland originated from the other source organs and/or was
merely stored. Therefore, from these observations we con-
cluded that the human pituitary gland is the ¢rst endocrine
gland in which the DNase I gene has been shown to be ex-
pressed to a substantial extent.
Fig. 1. IEF^PAGE (pH 3.5^5) patterns of desialylated DNase I
from pituitary gland (lanes 1^3), pancreas (lanes 4^6), and serum
(lanes 7^9) samples detected by activity staining using the DAFO
method. Paired samples were obtained from the same individuals.
Details of the analytical conditions are described elsewhere [13]. In
genetic polymorphism of human DNase I, three common pheno-
types (1, 1^2, and 2) have been classi¢ed on the basis of di¡erences
in electrophoretic patterns revealed by IEF^PAGE [18]: lanes 1, 4,
and 7 (type 1); lanes 2, 5, and 8 (type 1^2); lanes 3, 6, and 9 (type
2). The anode is at the top.
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3.3. Age-dependent alteration of DNase I activity in the
human pituitary gland
In order to examine potential e¡ects of age on the DNase I
activity, the activities of DNases I and II were determined in
paired samples of the pituitary gland and pancreas (together
with the serum samples) obtained from di¡erent individuals
aged from 1 month to 89 years. As shown in Fig. 2a, all the
pituitary gland samples from the individuals aged from
1 month to 9 years in both sexes in the neonatal and prepu-
bertal periods exhibited low or undetectable levels of activity.
In contrast, a marked age-dependent increase of the DNase I
activity in the pituitary samples from individuals over 16 years
old was observed in the reproductive period irrespective of
their gender, followed by a gradual age-dependent decline in
males and a low level in females in their postreproductive
period. The DNase I activity in the pituitary gland was age-
dependent regardless of gender. However, there were no such
age-related alterations in the activity levels of the enzyme in
the pancreas samples from the same individuals (Fig. 2b).
Similarly, the age of the subjects did not a¡ect the levels of
serum DNase I activity signi¢cantly (Table 1). Although ex-
pressed from the same gene, the activity levels of DNase I in
the pituitary gland exhibits a signi¢cant age-related alteration,
whereas this is not the case in the pancreas and serum.
DNase II (EC 3.1.22.1) is known to be another major type
Fig. 2. Age-dependent distributions of DNase I activity in (a) hu-
man pituitary gland and (b) pancreas (b, males; a, females).
Eighty-¢ve samples of human pituitary gland, together with pan-
creas samples that were collected simultaneously, were used to deter-
mine the levels of DNase I activity by the SRED method.
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of DNase present in mammalian tissues, including in the pi-
tuitary gland [20]. In contrast to DNase I, no age-related
changes in the levels of DNase II activity were observed in
the pituitary gland (Table 1). Thus, among the two major
types of DNase in the pituitary gland, only DNase I activity
was con¢rmed to be signi¢cantly age-dependent.
3.4. Age-dependent expression of the DNase I gene transcript
in human pituitary glands
Higher amounts of the DNase I gene transcript were ex-
pressed in the pituitary gland samples (5U1032^5U1033
amol/Wg total RNA; n = 8), with more than 0.4 U/g of the
DNase I activity of the subjects from the reproductive stages.
On the other hand, expression levels of the DNase I gene
(n = 5) from the neonatal and prepubertal stages were found
to be below the detection limit (1035 amol/Wg total RNA) of
our method. Furthermore, the amounts of gene transcript in
the pituitary gland samples (n = 5) with less than 0.05 U/g of
the activity from the postreproductive stage were less than one
tenth of those from the pubertal and reproductive stages.
These levels of DNase I-speci¢c mRNA expressed in each
pituitary gland sample correlated well with those of DNase
I activity measured in the corresponding tissue extraction, and
are consistent with previous ¢ndings [5,7,21]. On the other
hand, no signi¢cant di¡erence in the expression levels of the
DNase II-speci¢c mRNA in corresponding pituitary gland
samples from individuals of di¡erent ages could be observed
(data not shown), indicating that the mRNA might not be
degraded particularly rapidly in samples from neonates and
prepubertal individuals. Therefore, elevation of pituitary
gland DNase I activity after the prepubertal stage appears
to be due to up-regulation of the DNase I gene expression
rather than to recruitment of potential inhibitors such as G-
actin and/or to breakdown of DNase I protein molecules dur-
ing the neonatal and prepubertal stages. No signi¢cant age-
related di¡erences in the levels of the gene transcript among
the corresponding pancreas samples were observed. These
¢ndings provide strong evidence that expression of DNase I
gene in the pituitary gland is regulated in an age-dependent
manner.
4. Discussion
To our knowledge, the ¢nding of an age-related alteration
of DNase I activity in the human pituitary gland is the ¢rst to
demonstrate that physiological factors such as aging could
a¡ect DNase I gene expression in vivo. The abrupt elevation
of DNase I activity coincided with the onset of puberty in
both sexes (Fig. 2a). The onset of puberty is controlled by
the reactivation (disinhibition) of the human hypothalamic
luteinizing hormone-releasing hormone (LH-RH) pulse gener-
ator, leading to increased amplitude and frequency of LH-RH
secretion and an increase in sensitivity of the pituitary gland
to LH-RH [22,23]. With regard to the e¡ects of LH-RH on
gonadotropin subunit synthesis within the gonadotrope cells
of the pituitary gland, it is well documented that the primary
interaction of LH-RH with the membrane receptor initiates
multiple events inside the cells, including Ca2 mobilization,
inositol phospholipid hydrolysis, and cAMP accumulation
[24]. The human DNase I gene contains two sites correspond-
ing to a unique sequence of the cis-element that confers cAMP
responsiveness on the gene through a cAMP-responsive ele-
ment-binding protein [15]. Previously we suggested that down-
regulation of the DNase I gene by somatostatin might result
from a decrease of cAMP concentration through a G protein-
coupled signaling pathway [7]. In fact, a signi¢cant elevation
of the DNase I activity in rat pituitary glands was observed in
response to administration of LH-RH (Yasuda et al., unpub-
lished data). Therefore, since LH-RH is capable of increasing
both diacylglycerol and cAMP production within gonado-
trope cells [25], it seems plausible that LH-RH is involved
in up-regulation of the DNase I gene through the two intra-
cellular pathways implicated in the successive activation of
protein kinase C and then A in the same manner as the ex-
pression of the gonadotropin genes. Several cardinal hormo-
nal characteristics of puberty such as increased gonadal ste-
roids, growth hormone, and insulin-like growth factor I
secretions have been con¢rmed; an abrupt elevation of DNase
I gene expression in the pituitary gland might be regarded as
one of the characteristics of puberty.
Over about 50 years of age, the male pituitary gland DNase
I activity decreased slowly with age, whereas in females the
decrease was much more rapid (Fig. 2a). However, the levels
of DNase I activity in pancreas and serum were approxi-
mately constant (Table 1). The menopausal cessation of ovar-
ian function (follicular development) leads to decreased secre-
tion of estradiol and inhibin, with consequent loss of negative
feedback to the hypothalamus and pituitary gland in the hy-
pothalamic^pituitary^ovarian axis: the serum levels of gona-
dotropins, follicle-stimulating hormone, and LH increase [26].
In contrast, men do not experience an analogous rapid total
cessation of Leydig cell or seminiferous tubule function with
old age, and the decline in male sexual function with age does
not appear to be endocrine-mediated: the decline in the func-
tion of hypothalamic^pituitary^testicular axis is gradual [27].
Although the role and mechanism underlying DNase I gene
expression is still to be elucidated in the pituitary gland, the
di¡erences in the reduction of responses between the sexes
suggest that the enzyme activity coincides with hormonal
changes or old age. Also, age-related di¡erences in both the
DNase I activity and amount of gene transcript between the
pituitary gland and pancreas revealed that DNase I gene ex-
pression in these tissues is regulated in a tissue-speci¢c man-
ner. Previously, based on the di¡erences in response to so-
matostatin, tissues containing DNase I could be classi¢ed
into two types: somatostatin-sensitive and somatostatin-resis-
tant [7]. Elucidation of tissue-speci¢c hormonal regulation of
DNase I is currently under way in our laboratory.
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